NeuroEM Therapeutics, Inc.
Transcranial electromagnetic treatment (TEMT) device for non-invasive brain stimulation to disaggregate toxic protein oligomers in Alzheimer's disease
- Sector
- Medtech
- Headquarters
- Phoenix, AZ
- Latest Form D
- $1.9M, Apr 2025
- Total capital
- $5.7M
- Federal grants
- $3.4M
- 3 awards · 2016–2023
- Rank in peer group#283 of 538
- Private capital raised
- $2.3M
- 2 Form D · last Apr 2025
- 18 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 7
- 8 pending · first 2020
- Rank in peer group#86 of 538
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 2nd filing$1.9M
- Private capital raisedForm D · SEC · 1st filing$360K
- Federal grantHealth and Human S · Phase II · Disaggregation of Toxic Protein Oligomers in Brain with ElectromagneticTreatment$984K
- Federal grantHealth and Human S · Phase II · Disaggregation of Toxic Protein Oligomers in Brain with ElectromagneticTreatment$2.1M
- Federal grantHealth and Human S · Phase I · Disaggregation of Toxic Protein Oligomers in Brain with Electromagnetic Treatment$255K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Federal first
90months
from NeuroEM Therapeutics, Inc.’s first federal award to its first private round.
- First federal award · Dec 2016
- Health and Human S · $255K
- First Form D · Jun 2024
- $360K · 1st Form D
- Awards before first raise
- 3 awards
An association in public records, not a cause or a prediction.
Standing among 538 peers
Line = medianMedtech · Device
- Federal grantsBelow median
- Granted patents#86 · top 16%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- Chuck PapageorgiouExecutive Officer, DirectorNamed in SEC Form D filings
- Jonathan GordonDirectorNamed in SEC Form D filings
- Mitch LarimoreDirectorNamed in SEC Form D filings
What it has protected
USPTO · 7 granted of 15- GrantedBrain Immunoregulation Through Transcranial Electromagnetic TreatmentUSPTOUS 12,318,624
- GrantedTreatment Of Primary And Metastatic Brain Cancers By Transcranial Electromagnetic TreatmentUSPTOUS 11,911,629
- GrantedSystems For Sensing Proper Emitter Array PlacementUSPTOUS 11,813,472
Show all 15 patent records
- Brain Immunoregulation Through Transcranial Electromagnetic TreatmentJun 3, 2025 · US 12,318,624Granted
- Treatment Of Primary And Metastatic Brain Cancers By Transcranial Electromagnetic TreatmentFeb 27, 2024 · US 11,911,629Granted
- Systems For Sensing Proper Emitter Array PlacementNov 14, 2023 · US 11,813,472Granted
- Transcranial Electromagnetic TreatmentOct 24, 2023 · US 11,794,028Granted
- Immunoregulation, Brain Detoxification, And Cognitive Protection By Electromagnetic TreatmentSep 19, 2023 · US 11,759,650Granted
- Systems For Controlling Power To Differently Loaded Antenna ArraysSep 12, 2023 · US 11,752,356Granted
- Increased Human Life Span And Health Span Through Transcranial Electromagnetic TreatmentFeb 16, 2023 · Application 17975820Pending
- Electromagnetic Treatment Of Brain And Body DisordersSep 8, 2020 · US 10,765,879Granted
- Transcranial Electromagnetic TreatmentApplication PCTUS2020029563Pending
- Transcranial Electromagnetic TreatmentApplication 62884513Pending
- Brain Immunoregulation And Increased Human Life Span Through Transcranial Electromagnetic TreatmentApplication PCTUS2021056328Pending
- Immunoregulation, Brain Detoxification, And Cognitive Protection By Electromagnetic TreatmentApplication PCTUS2020031192Pending
- Treatment Of Primary And Metastatic Brain Cancers By Transcranial Electromagnetic TreatmentApplication PCTUS2021061272Pending
- Electromagnetic Treatment Of Brian And Body DisordersApplication PCTUS2014023805Pending
- Systems For Controlling Power To Differently Loaded Antenna ArraysApplication PCTUS2019017650Pending
Related companies, and why
- ELM TREE MEDICAL INC.Similar federal contract value in Medtech · null in contracts
- IFIT PROSTHETICS, LLCSimilar federal contract value in Medtech · null in contracts
- SUBTLE TECHNOLOGY LLCSimilar federal contract value in Medtech · null in contracts
- AMES TECHNOLOGY, INC.Similar federal contract value in Medtech · null in contracts
- OnLume Inc.Similar federal contract value in Medtech · null in contracts
- Polyvascular CorpSimilar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .